SynAffix Company Profile

17:24 EDT 20th June 2018 | BioPortfolio

SynAffix is a protein engineering company located in Oss (the Netherlands), focused on the development of next-generation Antibody-Drug Conjugates (ADCs) for targeted cancer and other diseases. SynAffix’ proprietary site-specific bioconjugation technology (GlycoConnectTM) enables the attachment of a toxic drug to a glycoprotein of interest without requiring prior engineering of the protein, thereby preserving its integrity and avoiding complex and time-consuming steps. GlycoConnectTM allows a rapid conversion of any off-the-shelf or de novo monoclonal antibody into a homogeneous and stable ADC. The general applicability and versatility of GlycoConnectTM to modify virtually any glycoprotein –including monoclonal antibodies – has the potential to be a powerful asset in the construction of stable and homogeneous ADCs, a promising novel class of targeted cancer therapeutics.


Pivot park, RE building
Molenstraat 110
5342 CC


Phone: +31 (0)88 022 4505
Fax: +31 (0)88 022 4555

News Articles [3 Associated News Articles listed on BioPortfolio]

Synaffix: Enables ADCs for oncology that are both safer and more effective as well as easier to manufacture

Formed in 2010, Synaffix BV is a Netherlands-based biotechnology company exclusively focused on continued advancement of our best-in-class antibody-drug conjugate (ADC) technology platform. As a lead...

Synaffix Further Strengthens Its Scientific Advisory Board with the Addition of John Lambert PhD, Former CSO of ImmunoGen

Synaffix B.V. announced today the expansion of its Scientific Advisory Board (SAB) with the addition of Dr. John M. Lambert, the former Chief Scientific Officer of ImmunoGen, In...

Synaffix BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummarySynaffix BV Synaffix is a biotechnology company that develops sitespecific antibodydrug conjugates technology platforms. The company develops its products through its proprietary technology and...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


SynAffix is a protein engineering company located in Oss (the Netherlands), focused on the development of next-generation Antibody-Drug Conjugates (ADCs) for targeted cancer and other diseases. SynA...

SynAffix BV

SynAffix BV, is a Netherlands-based biotechnology company backed by Aravis, BioGeneration Ventures, BOM Capital and MS Ventures, the strategic corporate venture capital fund of Me...

More Information about "SynAffix" on BioPortfolio

We have published hundreds of SynAffix news stories on BioPortfolio along with dozens of SynAffix Clinical Trials and PubMed Articles about SynAffix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SynAffix Companies in our database. You can also find out about relevant SynAffix Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record